# Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells

**Authors:** Methi Wathikthinnakon, Piriya Luangwattananun, Nunghathai Sawasdee, Chutipa Chiawpanit, Vannajan Sanghiran Lee, Piyarat Nimmanpipug, Yingmanee Tragoolpua, Siriphorn Rotarayanont, Thanich Sangsuwannukul, Nattaporn Phanthaphol, Yupanun Wutti‑in, Chalermchai Somboonpatarakun, Thaweesak Chieochansin, Mutita Junking, Jatuporn Sujjitjoon, Pa‑thai Yenchitsomanus, Aussara Panya

PMC · DOI: 10.1038/s41598-025-88644-7 · Scientific Reports · 2025-02-06

## Full-text entities

- **Diseases:** cholangiocarcinoma (MESH:D018281)
- **Chemicals:** gemcitabine (MESH:D000093542)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11802778/full.md

---
Source: https://tomesphere.com/paper/PMC11802778